P. Sonneveld

Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders

F. M. Ross, Hervé Avet‐Loiseau, Geneviève Ameye et al. · Haematologica · 2012 · 317 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Pathology +16

Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial

Christoph Scheid, P. Sonneveld, Ingo Schmidt‐Wolf et al. · Haematologica · 2013 · 126 citations · Full text

Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial

P. Sonneveld, Bronno van der Holt, Christine M. Segeren et al. · Haematologica · 2007 · 80 citations · Full text

Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology Oncology

Bouke P. C. Hazenberg, Alexandra Croockewit, Bronno van der Holt et al. · Haematologica · 2015 · 22 citations · Full text

Cell Therapy, Solid Organ Transplantation, Extended Survival +18